Sat.Sep 14, 2024

article thumbnail

STAT+: Pfizer drug shows promise in cancer-related condition that causes weight loss and weakness

STAT

BARCELONA, Spain — Patients with advanced cancers often develop a secondary condition that causes them to shed weight, making it even harder to tolerate their cancer treatments. Called cachexia, it’s an under-recognized syndrome that researchers are still trying to tease out, and one that’s attracting more interest from drugmakers.

288
288
article thumbnail

ESMO 2024 – Today’s oncological roots are branching

pharmaphorum

ESMO 2024 began on Friday 13th September. Prof Andres Cervantes discussed how building trust has been a several generation development, following five decades of effort in the oncological space.

114
114
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial

STAT

BARCELONA, Spain — A widely used immunotherapy approach helped stave off disease progression in patients with a type of anal tumor, researchers reported Saturday, potentially setting up the drug for approval in a cancer that’s largely caused by human papillomavirus.  The Phase 3 trial tested the PD-1 targeting antibody retifanlimab in combination with chemotherapy versus chemotherapy alone in patients with recurrent or metastatic squamous cell carcinoma of the anal canal.

article thumbnail

Passing of Biosecure Act a positive development

Express Pharma

We have been observing a steady change since the pandemic, where global pharma companies are increasingly looking to India and Southeast Asia as alternative supply chain destinations. The recent news in the USA ( the passing of the Biosecure Act by the US House of Representatives) has accelerated the need for supply chain resilience, which is expected to be a long-term strategic shift.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

TIGIT drug from iTeos shrinks lung tumors in trial

BioPharma Dive

Results presented at ESMO showed tumor response rates that matched the bar set by analysts for success. But they may not yet be enough to dispel doubts around TIGIT as a target.

72
article thumbnail

Emerging Frontiers: The Gut Microbiome's Role in Enhancing Cancer Immunotherapy and Treatment Outcomes

Pharmacy Times

An ESMO 2024 presentation explores the growing role of the gut microbiome in immunotherapy response, emerging diagnostic tools such as PCR chips, and innovative therapies such as fecal microbiota transplantation and microbiome-preserving strategies to improve patient outcomes.

59
article thumbnail

Unveiling the Microbiota's Role in Cancer: From Tumorigenesis to Treatment

Pharmacy Times

The gut and intratumoral microbiota influence cancer development, progression, and treatment responses, highlighting the potential for treatment strategies that leverage these microbial interactions to enhance cancer therapies.

26